A.M. Vitals: Amgen’s Osteoporosis Drug Gets FDA Okay


Published On: June 2nd, 2010

Also: the price tag for a tobacco tax loophole; the downside of shorter hospital stays; unique research on Alzheimer’s prevention.

See original here:
A.M. Vitals: Amgen’s Osteoporosis Drug Gets FDA Okay



Loading...


Comments are closed.